Severe Upper Limb Tremor Refractory to Medical Therapy Clinical Trial
— DB-SRSOfficial title:
Deep Brain Stimulation and Frameless Stereotactic Radiosurgery in the Treatment of Drug Resistant Invalidating Tremor
NCT number | NCT02095600 |
Other study ID # | DB-SRS |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | April 2011 |
Est. completion date | July 2017 |
Verified date | March 2019 |
Source | Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Stereotactic lesioning of thalamus and basal ganglia for treatment of tremor is a well-known
procedure which, prior to the introduction of deep brain stimulation, or DBS, was usually
achieved using stereotactic surgical procedures.
Radiosurgery of invisible targets to treat movement disorders and intractable pain are still
the domain of frame-based procedures, due to the need of a solid reference system registered
to the anterior commissure-posterior commissure (AC-PC) line, which allows the use of
stereotactic atlases.
In this study we want to utilize a mathematical method that uses atlas-derived stereotactic
coordinates to perform frameless images-guided radiosurgery of such functional targets
Particularly the aim of the present study is to investigate both the efficacy and the safety
of the methodology to treat upper limb and hand tremor in elderly or in patients which are
not ot susceptible of surgical procedures. For these reasons a dose escalation prospective
trial have been designed.
Status | Completed |
Enrollment | 6 |
Est. completion date | July 2017 |
Est. primary completion date | December 2016 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - patients affected by severe upper limb tremor refractory to medical therapy and who are candidate for a deep brain stimulation (DBS) procedure. - Age: = 18 years old - Refusal of DBS procedure - Written consent Exclusion Criteria: - Pregnancy - Allergy to contrast medium - DBS procedure susceptibility, if not refused |
Country | Name | City | State |
---|---|---|---|
Italy | Fondazione IRCCS Istituto Neurologico C. Besta, Unit of Radiotherapy | Milan |
Lead Sponsor | Collaborator |
---|---|
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta |
Italy,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Tremor control (improvement in FTMTRS and/or UPDRS motor) | Tremor control (improvement in Fahn Tolosa Marin Tremor Rating Scale, FTMTRS, and/or Unified Parkinson's Disease Rating Scale, UPDRS, motor) | 2 years | |
Secondary | Targeting methodology validation (the lesions position, if present, will be compared to the treatment plan target position, deviations will be registered). | 2 years | ||
Secondary | The treatment safety will be evaluated. Toxicity will be registered according to NCI-CTCAE v3. | The treatment safety will be evaluated. Toxicity will be registered according to National Cancer Institute-Common Terminology Criteria for Adverse Events Version 3,NCI-CTCAE v3. | 2 years |